Skip to main content
Signal8

ROCKET PHARMACEUTICALS, INC. (RCKT)

Rocket Pharmaceuticals, Inc., operating alongside its affiliates, is an innovative biotechnology enterprise dedicated to pioneering gene therapies for rare and severely debilitating diseases. The company's active clinical pipeline features multiple promising programs. It is currently progressing three ex vivo lentiviral vector therapies aimed at specific genetic conditions: Fanconi anemia, characterized by a bone marrow defect that hinders blood cell production; leukocyte adhesion deficiency-I, an inherited disorder resulting in a compromised immune system; and pyruvate kinase deficiency, a rare autosomal recessive red blood cell ailment leading to chronic non-spherocytic hemolytic anemia. Complementing these, Rocket Pharmaceuticals also has an in vivo adeno-associated virus program underway for Danon disease, a serious multi-organ lysosomal storage disorder that tragically often results in early mortality due to heart failure. To facilitate its extensive research and development efforts, the company has established key licensing partnerships with esteemed institutions such as the Fred Hutchinson Cancer Research Center, European research bodies including CIEMAT and its collaborators (Centro de Investigacion Biomedica En Red and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz), UCL Business PLC (in conjunction with CIEMAT), The Regents of the University of California, and REGENXBIO, Inc. Rocket Pharmaceuticals, Inc. maintains its primary corporate location in Cranbury, New Jersey.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc.

NASDAQ:RCKTHealthcare
-3.94%$2.44
AH$2.40-1.64%vs close
Mkt Cap$267.85M
Float84.59M
O/S109.77M
Vol
$ Vol
RVOL
Inst Own74.7%
SI19.3%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$223.12M
Total Assets$330.45M
Free Cash Flow-$190.45M
Debt & Equity
Debt 8%
Equity 92%
Total Debt$24.88M
Total Equity$277.22M
Shares Outstanding
Short Interest
Split History

No splits on record

Nothing in RCKT's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details
Assets$330.45M
Liabilities$53.23M
Accounts Receivable$0
Accounts Payable$0
Inventory$0
PP&E (Net)$71.59M
Goodwill$39.15M
Intangible Assets$25.15M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
YoY Growth--------------
Cost of Revenue$11.03M$0$0$0$0$1.15M$426K$330K$204K$169K$45K$0$0$0
Gross Profit-$11.03M$0$0$0$0-$1.15M-$426K-$330K-$204K-$169K-$45K$0$0$0
Gross Margin--------------
Research and Development$142.01M$171.24M$186.34M$165.57M$125.48M$106.38M$58.62M$53.27M$14.19M$31.98M$12.55M$5.59M$5.33M$3.54M
Selling, General, and Administrative$86.5M$101.96M$73.32M$58.77M$41.77M$27.92M$17.53M$17.89M$12.54M$9.89M$7.84M$2.11M$1.32M$2.31M
Other-$11.03M$0$0$0$0$0-$250K-$186K$0$0$0$0$3K$4K
Total Operating Expenses$217.49M$273.2M$259.66M$224.34M$167.25M$134.86M$75.9M$70.97M$26.74M$41.88M$20.4M$7.7M$6.65M$5.85M
Operating Income (EBIT)-$228.52M-$273.2M-$259.66M-$224.34M-$167.25M-$136M-$76.15M-$71.16M-$26.74M-$41.88M-$20.4M-$7.7M-$6.65M-$5.85M
Operating Margin--------------
Interest Expense$1.89M$1.89M$1.88M$1.91M$5.89M$7.55M$4.78M$5.24M$3.58M$1.42M$1.23M$980K$884K$213K
Interest Income$10.62M$18.22M$15.94M$3.89M$3.07M$2.15M$3.41M$1.69M$819K$443K$89K$0$0$0
Other Income (Expense)$5.39M$14.46M$14.06M$2.48M-$1.82M-$3.7M-$1.12M-$3.36M-$2.76M-$975K-$47.59M-$1.83M-$962K-$209K
Income Before Tax (EBT)-$223.12M-$258.75M-$245.59M-$221.86M-$169.07M-$139.7M-$77.27M-$74.52M-$29.5M-$42.85M-$67.98M-$9.53M-$7.62M-$6.06M
Income Tax Expense$0$0$0$0$0$6.97M$0$0$0$0$0$0$0$0
Net Income-$223.12M-$258.75M-$245.59M-$221.86M-$169.07M-$146.67M-$83.23M-$74.52M-$29.5M-$42.85M-$67.98M-$9.53M-$7.62M-$6.06M
Net Income Margin--------------
Supplementary Data
EPS-2.01-2.73-2.92-3.26-2.68-2.52-1.70-1.89-4.36-6.41-10.29-4.53-3.62-2.88
Diluted EPS-2.01-2.73-2.92-3.26-2.68-2.52-1.70-1.89-4.36-6.41-14.85-4.53-3.62-2.88
Weighted Average OS111.12M94.81M84.01M68.15M63.24M55.38M49.01M39.38M6.77M6.68M6.61M2.10M2.10M2.10M
EBITDA-$210.21M-$247.49M-$236.62M-$213.69M-$157.81M-$131.59M-$71.14M-$71.16M-$20.01M-$41.27M-$20.26M-$7.7M-$6.73M-$5.84M
EBITDA Margin--------------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$77.56M$163.63M$55.9M$140.52M$232.69M$297.1M$185.38M$111.36M$78.72M$29.8M$80.04M$3.62M$12.79M$1.37M
Short-Term Investments$111.37M$208.7M$317.27M$215.88M$156.05M$185.62M$118.73M$94.38M$21.29M$96.67M$31.24M$0$0$0
Cash and Short-Term Investments$188.93M$372.34M$373.18M$356.39M$388.74M$482.72M$304.12M$205.73M$100.01M$126.47M$111.28M$3.62M$12.79M$1.37M
Accounts Receivable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$3.81M$5.85M$5.05M$7.67M$0$0$0$3.36M$0$0$0$52K$0$0
Total Current Assets$192.73M$378.18M$378.22M$364.06M$392.06M$487.35M$307.75M$209.09M$101.05M$128.35M$112.37M$3.62M$12.86M$1.42M
Long-Term Assets
Property, Plant & Equipment Net$71.59M$83.32M$87.59M$77.64M$72.35M$70.64M$31.35M$2.03M$563K$1.13M$812K$0$0$0
Goodwill$39.15M$39.15M$39.15M$39.15M$30.82M$30.82M$30.82M$30.82M$0$0$0$0$0$0
Intangible Assets$25.15M$25.15M$25.15M$25.72M$0$0$226K$0$0$0$0$0$0$0
Long-Term Investments$1.34M$0$34.32M$43.28M$0$0$1.52M$7.4M$207K$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0-$1.57M-$1.52M$545K$0$0$0$0$0$0
Other Long-Term Assets$482K$1.89M$1.91M$1.95M$1.8M$3.59M$1.98M$1.44M-$39K$168K$143K$1.9M$4K$4K
Total Long-Term Assets$137.72M$149.52M$188.12M$187.75M$104.96M$103.48M$64.37M$42.23M$731K$1.3M$955K$1.9M$4K$4K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$330.45M$527.7M$566.34M$551.81M$497.02M$590.82M$372.12M$251.31M$101.78M$129.65M$113.32M$5.52M$12.86M$1.42M
Liabilities
Current Liabilities
Accounts Payable$0$1.63M$0$0$0$0$0$0$451K$1.59M$1.63M$1.15M$229K$387K
Short-Term Debt$0$0$0$0$0$4.88M$0$0$0$0$0$5.08M$1.41M$2.71M
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$590K$562K$534K$506K$478K$450K$421K$394K$367K
Other Current Liabilities$12.29M$185K$9.93M$10.01M$4.53M$2M$13.64M$12.93M$557K$2.97M$549K-$3.24M$468K-$207K
Total Current Liabilities$30.21M$40.68M$48.51M$39.17M$22.17M$32.62M$18.31M$15.37M$4.07M$7.21M$4.14M$3.7M$3.22M$3.77M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$35.07M$45.05M$41.45M$49.54M$48.96M$0$2.55M$5.39M$0
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$1.06M$1.14M$2.94M$2.6M$80K$136K$23K$457K$403K$307K$367K$50.83M$43.15M$28.59M
Total Long-Term Liabilities$23.02M$23.78M$25.26M$22.95M$20.13M$54.69M$46.52M$41.9M$49.94M$49.27M$367K$53.38M$48.54M$28.59M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$53.23M$64.47M$73.77M$62.12M$42.3M$87.31M$64.82M$57.28M$54.01M$56.48M$4.51M$57.08M$51.76M$32.35M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$41.47M$16K$0$46.8M$41.23M$28.56M
Common Stock$1.08M$1.06M$903K$791K$645K$610K$548K$452K$68K$270K$264K$10K$10K$10K
Retained Earnings-$1.44B-$1.22B-$959.37M-$713.77M-$491.91M-$322.84M-$183.14M-$105.87M-$268.37M-$238.88M-$196.02M-$128.04M-$118.51M-$110.89M
Comprehensive Income & Other-$31K$66K$319K-$357K-$161K-$42K$20K-$127K-$16K-$54K-$11K-$217K-$217K-$217K
Other Stockholders' Equity$1.72B$1.68B$1.45B$1.2B$945.99M$825.75M$489.89M$299.46M$316.07M$311.77M$304.57M$76.47M$79.61M$79.95M
Total Equity$277.22M$463.23M$492.57M$489.69M$454.72M$503.52M$307.3M$194.04M$47.76M$73.17M$108.81M-$51.56M-$38.9M-$30.93M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$330.45M$527.7M$566.34M$551.81M$497.02M$590.82M$372.12M$251.31M$101.78M$129.65M$113.32M$5.52M$12.86M$1.42M
Supplementary Data
Total Debt$24.88M$25.5M$25.04M$22.87M$22.6M$61.7M$47.45M$41.45M$49.54M$48.96M$0$7.15M$6.8M$2.71M
Net Debt-$52.68M-$138.14M-$30.86M-$117.65M-$210.09M-$235.4M-$137.93M-$69.91M-$29.18M$19.16M-$80.04M$3.54M-$5.99M$1.34M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$223.12M-$258.75M-$245.59M-$221.86M-$169.07M-$139.7M-$77.27M-$74.52M-$29.5M-$42.85M-$67.98M-$9.53M-$7.62M-$6.06M
Depreciation & Amortization$11.03M$9.38M$7.1M$6.27M$5.37M$1.15M$426K$330K$200K$169K$45K$0$0$9K
Deferred Income Tax$0$0$0$0$3.15M$999K-$1.07M-$484K$654K$225K$46.36M$0$0$2K
Stock-Based Compensation$37.06M$43.92M$39.41M$31.01M$29.24M$18.57M$13.37M$13.6M$4.04M$2.91M$2.38M$177K-$148K$486K
Changes in Working Capital:
  Accounts Receivable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0$0$0$9.67M-$4.83M$11.02M-$2.72M$5.89M-$1.14M-$41K$487K$917K-$158K$159K
  Other Working Capital-$8.3M$1.92M$13.46M-$3.6M$1.44M$4.01M-$1M-$1.5M-$886K$2.16M$182K-$2.39M$894K-$1.75M
Total Working Capital Change-$8.3M$1.92M$13.46M$6.08M-$3.39M$15.03M-$3.73M$4.38M-$2.03M$2.12M$669K-$1.47M$736K-$1.59M
Other Non-Cash Items-$6.68M-$6.19M-$9.28M$370K$13.53M$29.32M$3.6M$2.9M$522K$162K$1.11M$1.08M$573K$213K
Net Cash from Operating-$190.01M-$209.72M-$194.92M-$178.14M-$121.16M-$74.64M-$64.66M-$53.79M-$26.11M-$37.27M-$17.42M-$9.74M-$6.46M-$6.94M
Investing Activities
Capital Expenditures-$440K-$5.86M-$16.47M-$8.62M-$7.71M-$29.06M-$23.27M-$1.45M-$70K-$487K-$412K$0$0$0
Acquisitions$0$0$0$42.73M$95K$8.45M$16K$76.35M$0$0$0$0$0$0
Purchases of Investments-$276.55M-$245.89M-$390.92M-$376.33M-$245.88M-$209.34M-$184.3M-$141.09M-$27.2M-$122.28M-$33.69M$0$0$0
Sales of Investments$380.76M$383.45M$309.33M$272.89M$272.44M$141.81M$168.56M$61.28M$102.29M$56.7M$2.43M$0$0$0
Other Investing Activities$0$0$0$0-$95K-$8.45M-$16K-$356K$0$0$0$0$0$3K
Net Cash from Investing$103.77M$131.71M-$98.07M-$69.33M$18.85M-$96.59M-$39.01M-$5.27M$75.02M-$66.06M-$31.68M$0$0$3K
Financing Activities
Debt Repaid----------$48.74M-$13.36M-$560K-$7.92M-$2.5M
Common Stock Issuance$0$185.74M$208.39M$155.34M$37.68M$281.35M$178.1M$154.02M$35K$4M$112.05M$0$0$0
Common Stock Repurchases-$67K$0$0-$47K$0-$72K$0-$668K$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$215K$0-$132K-$172K-$201K-$3.85M-$313K$148K$19K$346K$106K$8K$0$0
Net Cash from Financing$148K$185.74M$208.4M$155.29M$37.68M$282.99M$177.79M$153.5M$25K$16$125.52M$568K$17.88M$2.5M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$86.1M$107.72M-$84.58M-$92.18M-$64.63M$111.76M$74.12M$94.44M$48.92M-$50.24M$76.42M-$9.18M$11.42M-$4.43M
Supplementary Data
Operating Cash Flow-$190.01M-$209.72M-$194.92M-$178.14M-$121.16M-$74.64M-$64.66M-$53.79M-$26.11M-$37.27M-$17.42M-$9.74M-$6.46M-$6.94M
Capital Expenditure-$440K-$5.86M-$16.47M-$8.62M-$7.71M-$29.06M-$23.27M-$1.45M-$70K-$487K-$412K$0$0$0
Free Cash Flow-$190.45M-$215.59M-$211.39M-$186.76M-$128.88M-$103.7M-$87.93M-$55.24M-$26.18M-$37.75M-$17.83M-$9.74M-$6.46M-$6.94M
Cash at Beginning$165M$57.28M$141.86M$234.04M$298.67M$186.91M$112.79M$18.35M$29.8M$80.04M$3.62M$12.79M$1.37M$5.8M
Cash at End$78.9M$165M$57.28M$141.86M$234.04M$298.67M$186.91M$112.79M$78.72M$29.8M$80.04M$3.62M$12.79M$1.37M